Atara Biotherapeutics

$13.99 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Atara Biotherapeutics

Atara Biotherapeutics, Inc. operates as a biotechnology company. The Company focuses on developing therapies for patients with severe and life-threatening diseases.

Stock Analysis

last close $13.99
1-mo return -10.1%
3-mo return -11.5%
avg daily vol. 787.81T
52-week high 21.85
52-week low 11.81
market cap. $1.4B
forward pe -
annual div. -
roe -98.8%
ltg forecast -
dividend yield -
annual rev. $13M
inst own. -

Subscribe now for daily local and international financial news